It has been reported that some chemotherapeutic agents, including DOX, induce the activation of NF-κB in cancer cells that inhibits apoptosis and promotes cancer growth and are also responsible in part for drug resistance in cancer cells [53–55]. This evidence concerns the gene NFKB1 and cancer.